Anti-CD19重组抗体|科研级 Inebilizumab ( 英比利珠单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-CD19重组抗体|科研级 Inebilizumab ( 英比利珠单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-CD19重组抗体|科研级 Inebilizumab ( 英比利珠单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1374

Alias

科研级 Inebilizumab ( 英比利珠单抗 ), Anti-CD19 Recombinant Antibody, Research Grade Inebilizumab

Molecular Name

Inebilizumab

Size

1mg, 5mg

CAS Number

1299440-37-1

Isotype

IgG1 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

CD19[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Inebilizumab, sold under the brand name Uplizna, is a medication for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults.The most common adverse reactions include urinary tract infection, headache, joint pain (arthralgia), nausea and back pain.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ